Device Trial Radar · NCT01048541
Bladder Scan of Residual Urine With New Catheter
Last checked: Nov 19, 2026Latest source record: Sep 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jan 2010
Primary completion
Jun 2010
Study completion Jun 2010
Sponsor
- Lead sponsor
- Coloplast A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 13, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Male intermittent catheters (ICs) range from 340-500 mm long, with the European standard minimum length being 360 mm for a catheter without a balloon and 275 mm for one with a balloon. This length is defined by hospital standards although it is known that the male urethra has an approximate maximum length of 29 cmA new intermittent catheter developed by Coloplast A/S is a 30-cm-long sterile, ready-to-use, hydrophilic-coated male catheter. There is a lack of clinical data documenting that male ICs that are shorter and more or less flexible than standard catheters can sufficiently empty the bladder of male subjects. This will be tested using ultrasound to measure residual urine in the bladder following catheterisation with new product and standard length catheter.
Conditions
- Urinary Incontinence
Interventions
Test Catheter - SpeediCath Compact MaleDevice
Compact catheter for intermittent catheterisation
SpeediCathDevice
Catheter for intermittent catheterisation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Residual Urine VolumeTime frame: 3 catheterisations on 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Werner-Wicker-Klinik, Abteilung für Neuro-Urologie
Bad Wildungen, Hesse, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.